Logo-bi
Original Research
Siddharth Singh Yadav, Basant Singh Sikarwar* ORCID, Priya Ranjan, Rajiv Janardhanan
Bioimpacts. 2020;10(3): 141-150. doi: 10.34172/bi.2020.18
PMCID: PMC7416008     PMID: 32793436     Scopus ID: 85089711145    
We proposed making a case for the validation of a low-cost version of a microfluidic system capable of scanning large populations for a variety of diseases as per the WHO mandate of “One Health”.
Original Research
Mitra Moeinzadeh ORCID, Babak Kheirkhah* ORCID, Kumarss Amini ORCID, Ali Pouryasin ORCID
Bioimpacts. 2020;10(4): 235-242. doi: 10.34172/bi.2020.30
PMCID: PMC7502904     PMID: 32983939     Scopus ID: 85092032467    
High prevalence of HPV- 53 and HPV-16 detected among participants with normal cytology can be considered as a tip-off development of cervical cancer among Iranian women.
Original Research
Mohammad Amjadi* ORCID, Tooba Hallaj, Niko Hildebrandt
BioImpacts. 2021;11(3): 173-179. doi: 10.34172/bi.2021.23
PMCID: PMC8314039     PMID: 34336605     Scopus ID: 85109081799    
A fluorescence method based on Tb-to-QD time-resolved FRET was developed for G9a assay.
Letter to the Editor
Aleksandr L. Urakov* ORCID, Natalya A. Urakova, Ilnur I. Yagudin, Milena D. Svetova, Darya O. Suntsova
BioImpacts. 2022;12(4): 393-394. doi: 10.34172/bi.2022.23877
PMCID: PMC9376158     PMID: 35975207     Scopus ID: 85138077187    
The purpose of this letter was to present a model for evaluating the biological activity of drugs, which can become a new vector for the development of effective ways to increase blood oxygenation across pulmonary and save the lives of patients with severe atypical pneumonia complicated by respiratory obstruction in COVID-19.
Original Article
Navid Mohammadjani ORCID, Sahand Karimi, Musa Moetasam Zorab ORCID, Morahem Ashengroph* ORCID, Mehran Alavi* ORCID
Bioimpacts. 2024;14(2): 27778. doi: 10.34172/bi.2023.27778
PMCID: PMC10945298     PMID: 38505671     Scopus ID: 85175876168    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge